Progress on long non-coding RNAs in calcific aortic valve disease

Calcific aortic valve disease (CAVD) is a common cardiovascular condition in the elderly population. The aortic valve, influenced by factors such as endothelial dysfunction, inflammation, oxidative stress, lipid metabolism disorders, calcium deposition, and extracellular matrix remodeling, undergoes...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Shen, Jiahui Li, Zehao Zhao, Xiaomin Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2025.1522544/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841525875024068608
author Yan Shen
Jiahui Li
Zehao Zhao
Xiaomin Chen
author_facet Yan Shen
Jiahui Li
Zehao Zhao
Xiaomin Chen
author_sort Yan Shen
collection DOAJ
description Calcific aortic valve disease (CAVD) is a common cardiovascular condition in the elderly population. The aortic valve, influenced by factors such as endothelial dysfunction, inflammation, oxidative stress, lipid metabolism disorders, calcium deposition, and extracellular matrix remodeling, undergoes fibrosis and calcification, ultimately leading to stenosis. In recent years, long non-coding RNAs (lncRNAs) have emerged as significant regulators of gene expression, playing crucial roles in the occurrence and progression of various diseases. Research has shown that lncRNAs participate in the pathological process underlying CAVD by regulating osteogenic differentiation and inflammatory response of valve interstitial cells. Specifically, lncRNAs, such as H19, MALAT1, and TUG1, are closely associated with CAVD. Some lncRNAs can act as miRNA sponges, form complex regulatory networks, and modulate the expression of calcification-related genes. In brief, this review discusses the mechanisms and potential therapeutic targets of lncRNAs in CAVD.
format Article
id doaj-art-b85e84eba2d54208a8caba8252957508
institution Kabale University
issn 2297-055X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj-art-b85e84eba2d54208a8caba82529575082025-01-17T06:50:34ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2025-01-011210.3389/fcvm.2025.15225441522544Progress on long non-coding RNAs in calcific aortic valve diseaseYan Shen0Jiahui Li1Zehao Zhao2Xiaomin Chen3Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaDepartment of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Zhejiang University, Hangzhou, ChinaDepartment of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaCalcific aortic valve disease (CAVD) is a common cardiovascular condition in the elderly population. The aortic valve, influenced by factors such as endothelial dysfunction, inflammation, oxidative stress, lipid metabolism disorders, calcium deposition, and extracellular matrix remodeling, undergoes fibrosis and calcification, ultimately leading to stenosis. In recent years, long non-coding RNAs (lncRNAs) have emerged as significant regulators of gene expression, playing crucial roles in the occurrence and progression of various diseases. Research has shown that lncRNAs participate in the pathological process underlying CAVD by regulating osteogenic differentiation and inflammatory response of valve interstitial cells. Specifically, lncRNAs, such as H19, MALAT1, and TUG1, are closely associated with CAVD. Some lncRNAs can act as miRNA sponges, form complex regulatory networks, and modulate the expression of calcification-related genes. In brief, this review discusses the mechanisms and potential therapeutic targets of lncRNAs in CAVD.https://www.frontiersin.org/articles/10.3389/fcvm.2025.1522544/fullcalcific aortic valve diseaselong non-coding RNAvalve interstitial cellsosteogenic differentiationmechanisms
spellingShingle Yan Shen
Jiahui Li
Zehao Zhao
Xiaomin Chen
Progress on long non-coding RNAs in calcific aortic valve disease
Frontiers in Cardiovascular Medicine
calcific aortic valve disease
long non-coding RNA
valve interstitial cells
osteogenic differentiation
mechanisms
title Progress on long non-coding RNAs in calcific aortic valve disease
title_full Progress on long non-coding RNAs in calcific aortic valve disease
title_fullStr Progress on long non-coding RNAs in calcific aortic valve disease
title_full_unstemmed Progress on long non-coding RNAs in calcific aortic valve disease
title_short Progress on long non-coding RNAs in calcific aortic valve disease
title_sort progress on long non coding rnas in calcific aortic valve disease
topic calcific aortic valve disease
long non-coding RNA
valve interstitial cells
osteogenic differentiation
mechanisms
url https://www.frontiersin.org/articles/10.3389/fcvm.2025.1522544/full
work_keys_str_mv AT yanshen progressonlongnoncodingrnasincalcificaorticvalvedisease
AT jiahuili progressonlongnoncodingrnasincalcificaorticvalvedisease
AT zehaozhao progressonlongnoncodingrnasincalcificaorticvalvedisease
AT xiaominchen progressonlongnoncodingrnasincalcificaorticvalvedisease